Abry Partners

Abry Partners is a Boston-based private equity firm that executes large-scale buyouts and growth equity investments, with a particular concentration in healthcare information technology and healthcare software platforms. The firm targets established businesses with proven commercial traction rather than concept-stage technology, and its healthcare IT exposure means it tracks the broader software-enabled provider and payer ecosystem where AI tools increasingly operate. Public information about specific named portfolio companies in the healthcare AI segment is limited in the source data.

Abry writes checks of $25M and above into growth-stage opportunities, deploying capital primarily across the United States. The firm is not structured for early-stage venture, and its investment cadence reflects the typical PE model of larger, control-oriented or significant minority positions in companies that already have meaningful revenue.

For healthcare AI founders, Abry is a name to file away rather than approach now. It is not a fit for seed or Series A founders. The right time to engage is when a company has reached scaled annual recurring revenue, durable margins, and is contemplating a recapitalization, secondary, or buyout. Founders approaching exit-stage decisions or considering a PE-backed roll-up of adjacent assets are the relevant audience.